An Algorithm Combining Patient Performance Status, Second Hit Analysis, PROVEAN and Dann Prediction Tools Could Foretell Sensitization to PARP Inhibitors in Digestive, Skin, Ovarian and Breast Cancers.
PARP inhibitors
VUS
homologous recombination
progression-free survival
response
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Jun 2021
22 Jun 2021
Historique:
received:
30
04
2021
revised:
14
06
2021
accepted:
21
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
PARP inhibitors yield interesting outcomes for patients with ovarian tumors harboring
Identifiants
pubmed: 34206535
pii: cancers13133113
doi: 10.3390/cancers13133113
pmc: PMC8268870
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Canceropole EST
ID : Emergence 2017
Références
Hum Mutat. 2012 Jan;33(1):8-21
pubmed: 21990134
Br J Cancer. 2020 Aug;123(4):525-533
pubmed: 32523090
NPJ Breast Cancer. 2018 Jul 2;4:16
pubmed: 29978035
JCO Precis Oncol. 2018;2018:
pubmed: 30234181
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Genome Med. 2016 Jan 29;8(1):11
pubmed: 26825632
Breast Cancer Res. 2020 May 11;22(1):43
pubmed: 32393398
Oncotarget. 2015 Apr 30;6(12):10548-62
pubmed: 25868852
Lancet. 2017 Oct 28;390(10106):1949-1961
pubmed: 28916367
Hum Mutat. 2008 Nov;29(11):1265-72
pubmed: 18951437
Genome Res. 2014 Nov;24(11):1881-93
pubmed: 25060187
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
N Engl J Med. 2016 Dec;375(22):2154-2164
pubmed: 27717299
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
Br J Cancer. 2018 Nov;119(11):1401-1409
pubmed: 30353044
N Engl J Med. 2012 Apr 12;366(15):1382-92
pubmed: 22452356
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
N Engl J Med. 2019 Dec 19;381(25):2416-2428
pubmed: 31851799
Cancer Discov. 2013 Oct;3(10):1142-55
pubmed: 23867111
Trends Mol Med. 2017 Dec;23(12):1121-1137
pubmed: 29133135
Nat Commun. 2019 Nov 22;10(1):5296
pubmed: 31757951
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
Exp Mol Med. 2021 Jan;53(1):42-51
pubmed: 33487630
Clin Cancer Res. 2020 Jun 1;26(11):2487-2496
pubmed: 32086346
Bioinformatics. 2015 Mar 1;31(5):761-3
pubmed: 25338716
Mol Cancer Ther. 2013 Jun;12(6):865-77
pubmed: 23512992
Nat Rev Clin Oncol. 2011 May;8(5):302-6
pubmed: 21468130
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
World J Gastroenterol. 2016 Dec 28;22(48):10680-10686
pubmed: 28082821
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
EBioMedicine. 2020 Jan;51:102624
pubmed: 31923800
N Engl J Med. 2015 Oct 29;373(18):1697-708
pubmed: 26510020
Mod Pathol. 2018 Sep;31(9):1367-1380
pubmed: 29785016
Genome Biol. 2016 Feb 22;17:31
pubmed: 26899170
Nat Genet. 2019 May;51(5):912-919
pubmed: 30988514
Genome Biol. 2019 Nov 14;20(1):240
pubmed: 31727117
J Exp Clin Cancer Res. 2020 Mar 4;39(1):46
pubmed: 32127026
N Engl J Med. 2019 Dec 19;381(25):2391-2402
pubmed: 31562799
N Engl J Med. 2018 Aug 23;379(8):753-763
pubmed: 30110579